Biocryst Pharmaceuticals Inc (BCRX)

Nov 18, 2024

Primary Hyperoxaluria Drug Market SWOT Analysis by Leading Key Players: Pfizer, Novartis, BioCryst - openPR

Nov 18, 2024

Nov 18, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Sees Large Drop in Short Interest - MarketBeat

Nov 18, 2024

Nov 18, 2024

BioCryst Launches ORLADEYO® (berotralstat) in Ireland - GlobeNewswire

Nov 18, 2024

Nov 18, 2024

BioCryst's ORLADEYO Becomes First Oral HAE Treatment Approved in Ireland | BCRX Stock News - StockTitan

Nov 18, 2024

Nov 17, 2024

(BCRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 17, 2024

Nov 13, 2024

Avian influenza Treatment Market Growth Trends: Regional - openPR

Nov 13, 2024

Nov 12, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Sold by GSA Capital Partners LLP - MarketBeat

Nov 12, 2024

Nov 09, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Nov 09, 2024

Nov 07, 2024

Vanguard Group Inc's Strategic Acquisition in BioCryst Pharmaceu - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

HC Wainwright Has Optimistic Outlook of BCRX Q4 Earnings - MarketBeat

Nov 07, 2024

Nov 06, 2024

Ionis Looks Ahead To Commercializing Its Own Products - Citeline News & Insights

Nov 06, 2024

Nov 06, 2024

Objective long/short (BCRX) Report - Stock Traders Daily

Nov 06, 2024

Nov 06, 2024

BioCryst to Present at Upcoming Investor Conferences - GlobeNewswire

Nov 06, 2024

Nov 06, 2024

BioCryst (BCRX) to Present at Three Major Healthcare Investor Conferences | BCRX Stock News - StockTitan

Nov 06, 2024

Nov 05, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals (NASDAQ:BCRX) Posts Earnings Results, Hits Estimates - MarketBeat

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals' (BCRX) "Outperform" Rating Reiterated at Royal Bank of Canada - MarketBeat

Nov 05, 2024

Nov 05, 2024

Barclays Forecasts Strong Price Appreciation for BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock - MarketBeat

Nov 05, 2024

Nov 05, 2024

BCRXBioCryst Pharmaceuticals Inc Latest Stock News & Market Updates - StockTitan

Nov 05, 2024

Nov 05, 2024

Earnings call: BioCryst Pharmaceuticals reports strong Q3 growth - Investing.com India

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Nov 05, 2024

BioCryst Announces Strong Q3 2024 Revenue Growth - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals, Inc. Provides Financial Guidance for the Year 2024, Second Half of 2025 and Full Year of 2026 - Marketscreener.com

Nov 05, 2024

Nov 05, 2024

BioCryst Awards Key Talent with $8.01 Stock Options, RSU Compensation Package | BCRX Stock News - StockTitan

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highli - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ... - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 05, 2024

Nov 04, 2024

Earnings call: BioCryst Pharmaceuticals reports strong Q3 growth By Investing.com - Investing.com Australia

Nov 04, 2024

Nov 04, 2024

BioCryst: Q3 Earnings Snapshot - Darien Times

Nov 04, 2024

Nov 04, 2024

BioCryst shares hold Buy rating, BofA sees entry point By Investing.com - Investing.com Canada

Nov 04, 2024

Nov 04, 2024

Piper Sandler lifts BioCryst Pharma target to $21 on Q3 beat - Investing.com UK

Nov 04, 2024

Nov 04, 2024

BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript - AOL

Nov 04, 2024

Nov 04, 2024

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap DownHere's Why - MarketBeat

Nov 04, 2024

Nov 04, 2024

BioCryst Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 04, 2024

Nov 04, 2024

BioCryst Pharmaceuticals Q3 2024 Earnings: EPS Loss of $0.07, Re - GuruFocus.com

Nov 04, 2024

Nov 04, 2024

BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 04, 2024

Nov 02, 2024

BioCryst Pharmaceuticals Q3 2024 Earnings Preview - MSN

Nov 02, 2024

Nov 01, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Bought by Rice Hall James & Associates LLC - MarketBeat

Nov 01, 2024

Oct 31, 2024

‘Breakthrough’ quarter for Island Pharmaceuticals - The Mercury

Oct 31, 2024

Oct 31, 2024

Island Pharmaceuticals enjoys big quarter - Courier Mail

Oct 31, 2024

Oct 28, 2024

Semanteon Capital Management LP Invests $1.14 Million in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - MarketBeat

Oct 28, 2024

Oct 28, 2024

BioCryst Pharmaceuticals (BCRX) Scheduled to Post Earnings on Monday - MarketBeat

Oct 28, 2024

Oct 26, 2024

When (BCRX) Moves Investors should Listen - Stock Traders Daily

Oct 26, 2024

Oct 25, 2024

How Much Upside is Left in BioCryst (BCRX)? Wall Street Analysts Think 79.5% - MSN

Oct 25, 2024

Oct 24, 2024

What's Going On With BioCryst Pharmaceuticals Stock? - MSN

Oct 24, 2024

Oct 24, 2024

BioCryst Presents New Real-World Evidence Showing High - GlobeNewswire

Oct 24, 2024

Oct 24, 2024

BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat) - StockTitan

Oct 24, 2024

Oct 22, 2024

BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 4.7%Here's What Happened - MarketBeat

Oct 22, 2024